Regulation of cutaneous immunity by catecholamines

Neuroimmunology of the Skin: Basic Science to Clinical Practice

Volumn , Issue , 2009, Pages 65-74

  Seiffert, K ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 80052949110     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-35989-0_7     Document Type: Chapter

References (61)

1. Arnetz BB, Fjellner B, Eneroth P, et al (1985) Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 47:528-541.
2. Benschop RJ, Rodriguez-Feuerhahn M, Schedlowski M (1996) Catecholamine-induced leukocytosis: early observations, current research, and future directions. Brain Behav Immun 10:77-91.
3. Bos JD, Kapsenberg ML, Smitt JH (1994) Pathogenesis of atopic eczema. Lancet 343:1338-1341.
4. Botchkarev VA, Peters EM, Botchkareva NV, et al (1999) Hair cycle-dependent changes in adrenergic skin innervation, and hair growth modulation by adrenergic drugs. J Invest Dermatol 113:878-887.
5. Buske-Kirschbaum A, Geiben A, Hellhammer D (2001) Psychobiological aspects of atopic dermatitis: An overview. Psychother Psychosom 70:6-16.
6. Buske-Kirschbaum A, Ebrecht M, Kern S, et al (2006) Endocrine stress responses in TH1-mediated chronic inflammatory skin disease (psoriasis vulgaris) - do they parallel stress-induced endocrine changes in TH2- mediated inflammatory dermatoses (atopic dermatitis)? Psychoneuroendocrinology 31:439-446.
7. Chrousos GP (2000) Stress, chronic inflammation, and emotional and physical well-being: concurrent effects and chronic sequelae. J Allergy Clin Immunol 106:S275-S291.
8. Chrousos GP (2000) The stress response and immune function: clinical implications. Ann N Y Acad Sci 917:38-67.
9. Dhabhar FS (2002) Stress-induced augmentation of immune function - the role of stress hormones, leukocyte trafficking, and cytokines. Brain Behav Immun 16:785-798.
10. Dhabhar FS (2003) Stress, leukocyte trafficking, and the augmentation of skin immune function. Ann N Y Acad Sci 992:205-217.
11. Dhabhar FS, McEwen BS (1996) Stress-induced enhancement of antigen-specific cell-mediated immunity. J Immunol 156:2608-2615.
12. Dhabhar FS, McEwen BS (1999) Enhancing versus suppressive effects of stress hormones on skin immune function. Proc Natl Acad Sci U S A 96:1059-1064.
13. Drummond PD, Skipworth S, Finch PM (1996) Alpha 1-adrenoceptors in normal and hyperalgesic human skin. Clin Sci (Lond) 91:73-77.
14. Ehlers A, Stangier U, Gieler U (1995) Treatment of atopic dermatitis: A comparison of psychological and dermatological approaches to relapse prevention. J Consult Clin Psychol 63:624-635.
15. Felten DL, Felten SY, Carlson SL, et al (1985) Noradrenergic and peptidergic innervation of lymphoid tissue. J Immunol 135:755s-765s.
16. Felten SY, Madden KS, Bellinger DL, et al (1998) The role of the sympathetic nervous system in the modulation of immune responses. Adv Pharmacol 42:583-587.
17. Flint MS, Valosen JM, Johnson EA, et al (2001) Restraint stress applied prior to chemical sensitization modulates the development of allergic contact dermatitis differently than restraint prior to challenge. J Neuroimmunol 113:72-80.
18. Furlan C, Sterin-Borda L, Borda E (2005) Activation of beta3 adrenergic receptor decreases DNA synthesis in human skin fibroblasts via cyclic GMP/nitric oxide pathway. Cell Physiol Biochem 16:175-182.
19. Grando SA, Pittelkow MR, Schallreuter KU (2006) Adrenergic and cholinergic control in the biology of epidermis: physiological and clinical significance. J Invest Dermatol 126:1948-1965.
20. Grewe SR, Chan SC, Hanifin JM (1982) Elevated leukocyte cyclic AMP-phosphodiesterase in atopic disease: A possible mechanism for cyclic AMP-agonist hyporesponsiveness. J Allergy Clin Immunol 70:452-457.
21. Hasko G, Szabo C, Nemeth ZH, et al (1998) Stimulation of beta-adrenoceptors inhibits endotoxin-induced IL- 12 production in normal and IL-10 deficient mice. J Neuroimmunol 88:57-61.
22. Hoffman BB (2001) Adrenoceptor-activating and other sympathomimetic drugs. In: Katzung BG (ed) Basic and Clinical Pharmacology, Lange Medical Books/McGraw- Hill, New York.
23. Hosoi J, Tsuchiya T, Denda M, et al (1998) Modification of LC phenotype and suppression of contact hypersensitivity response by stress. J Cutan Med Surg 3:79-84.
24. Johnson M (2002) Effects of beta2-agonists on resident and infiltrating inflammatory cells. J Allergy Clin Immunol 110:S282-S290.
25. Kavelaars A (2002) Regulated expression of alpha-1 adrenergic receptors in the immune system. Brain Behav Immun 16:799-807.
26. Kiecolt-Glaser JK, McGuire L, Robles TF, et al (2002) Psychoneuroimmunology: psychological influences on immune function and health. J Consult Clin Psychol 70:537-547.
27. Kin NW, Sanders VM (2006) It takes nerve to tell T and B cells what to do. J Leukoc Biol 79:1093-1104.
28. Kohm AP, Sanders VM (2001) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487-525.
29. Leung DY, Soter NA (2001) Cellular and immunologic mechanisms in atopic dermatitis. J Am Acad Dermatol 44: S1-S12.
30. Madden KS, Sanders VM, Felten DL (1995) Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu Rev Pharmacol Toxicol 35:417-448.
31. Maestroni GJ (2000) Dendritic cell migration controlled by alpha 1b-adrenergic receptors. J Immunol 165:6743-6747.
32. Maestroni GJ (2002) Short exposure of maturing, bone marrow-derived dendritic cells to norepinephrine: impact on kinetics of cytokine production and Th development. J Neuroimmunol 129:106-114.
33. Maestroni GJ (2004) Modulation of skin norepinephrine turnover by allergen sensitization: impact on contact hypersensitivity and T helper priming. J Invest Dermatol 122:119-124.
34. Maestroni GJ, Mazzola P (2003) Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity. J Neuroimmunol 144:91-99.
35. Moroni F, Fantozzi R, Masini E, et al (1977) The modulation of histamine release by alpha-adrenoceptors: evidences in murine neoplastic mast cells. Agents Actions 7:57-61.
36. O'Brien M, Koo J (2006) The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis. J Drugs Dermatol 5:426-432.
37. Ozkur M, Erbagci Z, Nacak M, et al (2004) Association of the Arg16Gly polymorphism of the beta-2-adrenergic receptor with psoriasis. J Dermatol Sci 35:162-164.
38. Panina-Bordignon P, Mazzeo D, Lucia PD, et al (1997) Beta2-agonists prevent Th1 development by selective inhibition of interleukin 12. J Clin Invest 100:1513-1519.
39. Reed CE, Busse WW, Lee TP (1976) Adrenergic mechanisms and the adenyl cyclase system in atopic dermatitis. J Invest Dermatol 67:333-338.
40. Roguedas AM, Audrezet MP, Scotet V, et al (2006) Intrinsic atopic dermatitis is associated with a beta-2 adrenergic receptor polymorphism. Acta Derm Venereol 86:447-448.
41. Rosenfield RL, Wu PP, Ciletti N (2002) Sebaceous epithelial cell differentiation requires cyclic adenosine monophosphate generation. In Vitro Cell Dev Biol Anim 38:54-57.
42. Saint-Mezard P, Chavagnac C, Bosset S, et al (2003) Psychological stress exerts an adjuvant effect on skin dendritic cell functions in vivo. J Immunol 171:4073-4080.
43. Schallreuter KU (1997) Epidermal adrenergic signal transduction as part of the neuronal network in the human epidermis. J Investig Dermatol Symp Proc 2:37-40.
44. Schallreuter KU, Wood JM, Lemke R, et al (1992) Production of catecholamines in the human epidermis. Biochem Biophys Res Commun 189:72-78.
45. Schallreuter KU, Wood JM, Pittelkow MR, et al (1993) Increased in vitro expression of beta 2-adrenoceptors in differentiating lesional keratinocytes of vitiligo patients. Arch Dermatol Res 285:216-220.
46. Schallreuter KU, Pittelkow MR, Swanson NN, et al (1997) Altered catecholamine synthesis and degradation in the epidermis of patients with atopic eczema. Arch Dermatol Res 289:663-666.
47. Schedlowski M, Falk A, Rohne A, et al (1993) Catecholamines induce alterations of distribution and activity of human natural killer (NK) cells. J Clin Immunol 13:344-351.
48. Schmid-Ott G, Jaeger B, Adamek C, et al (2001) Levels of circulating CD8(+) T lymphocytes, natural killer cells, and eosinophils increase upon acute psychosocial stress in patients with atopic dermatitis. J Allergy Clin Immunol 107:171-177.
49. Seiffert K, Granstein RD (2006) Neuroendocrine regulation of skin dendritic cells. Ann N Y Acad Sci 1088:195-206.
50. Seiffert K, Hosoi J, Torii H, et al (2002) Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells. J Immunol 168:6128-6135.
51. Seiffert K, Hosoi J, Torii H, et al (2003) Epinephrine regulates TNF-expression in the Langerhans cell-like cell line XS106A. J Invest Dermatol 121:abstract 896.
52. Seiffert K, Hilbert E, Schaechinger H, et al (2005) Psychophysiological reactivity under mental stress in atopic dermatitis. Dermatology 210:286-293.
53. Steinkraus V, Korner C, Steinfath M, et al (1991) High density of beta 2-adrenoceptors in a human keratinocyte cell line with complete epidermal differentiation capacity (HaCaT). Arch Dermatol Res 283:328-332.
54. Steinkraus V, Steinfath M, Korner C, et al (1992) Binding of beta-adrenergic receptors in human skin. J Invest Dermatol 98:475-480.
55. Steinkraus V, Steinfath M, Stove L, et al (1993) Betaadrenergic receptors in psoriasis: evidence for downregulation in lesional skin. Arch Dermatol Res 285: 300-304.
56. Steinkraus V, Mak JC, Pichlmeier U, et al (1996) Autoradio - graphic mapping of beta-adrenoceptors in human skin. Arch Dermatol Res 288:549-553.
57. Takahashi H, Kinouchi M, Tamura T, et al (1996) Decreased beta 2-adrenergic receptor-mRNA and loricrin-mRNA, and increased involucrin-mRNA transcripts in psoriatic epidermis: Analysis by reverse transcription-polymerase chain reaction. Br J Dermatol 134:1065-1069.
58. Tausk FA, Christian E, Johansson O, et al (1993) Neurobiology of the skin. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen FK (eds) Dermatology in General Medicine, McGraw-Hill, New York.
59. Valladeau J, Saeland S (2005) Cutaneous dendritic cells. Semin Immunol 17:273-283.
60. Viswanathan K, Daugherty C, Dhabhar FS (2005) Stress as an endogenous adjuvant: Augmentation of the immunization phase of cell-mediated immunity. Int Immunol 17:1059-1069.
61. Wang B, Zhuang L, Fujisawa H, et al (1999) Enhanced epidermal Langerhans cell migration in IL-10 knockout mice. J Immunol 162:277-283.